5
Genotype of HCV-virus among high-risk groups in Albania
Authors: Brunilda Hysaj (Vila), Lila Shundi, Mimoza Basho, Silva Bino, Eriona Abazaj, Tefta Rexha
Number of views: 355
Aim: To determine the prevalence and HCV genotype among high risk groups in Albania.
Methods: In this study we analyzed 172 blood samples collected from various high risk groups for the presence and genotype of HCV virus with HCV-RNA (Cobas Amplicor HCV Test v2.0, Roche), HCV genotype (Line Probe Assay-LiPA, Bayer). The data analysis was done using SPSS, version 16.0.
Results: A total of 172 blood samples were screened including thalasemic patients, dialysis patients, and injecting drug users (IDUs). Initial screening was done for anti-HCV using ELISA-test. Confirmation of active HCV infection was carried out with the help of Cobas Amplicor test V 2.0. Out of 172 samples, 121 (70.34%) were both HCV positive for anti-HCV and HCV RNA. Prevalence of active HCV-RNA infection in individual risk groups was: 20 (41.66%) for 48 thalasemics patients, 74 (88%) for 84 cases with dialysis and 27 (67.5%) for 40 cases in injection drug users, respectively. Four major genotypes (1, 2, 3, 4) and their subtypes (1a, 1b, 1a/b, 3a, 4a, 4e) were identified. The most frequent HCV genotypes were 1 and 3. There was no significant relationship between virus genotypes and sex, age and risk-group.
Conclusions: The prevalence of HCV-RNA was higher in these population groups. Genotype 1, subtype 1b was the most prevalent in dialysis patients and genotype 3 was the most prevalent between the IDUs group, but more detailed studies with a larger number of patients are necessary to understand the HCV dynamics in this population subgroup of Albania.